2000
DOI: 10.1159/000018312
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Efficacy of Narrow-Band UVB (311 nm) Combined with Dithranol in Psoriasis

Abstract: Background: For UVB, the most effective wavelength in clearing psoriatic lesions was found to be of 313 nm. The efficacy of whole body exposure to narrow-band UVB (311 nm) combined with dithranol in psoriasis has not been evaluated to date. Objective: Evaluation of the clinical efficacy of phototherapy with narrow-band UVB (311 nm) and dithranol for psoriasis by means of whole body exposures and analysis of the mean cumulative irradiation dose. Methods: In this open pilot study, 13 patients were treated for 4–… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
12
0
2

Year Published

2003
2003
2024
2024

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(16 citation statements)
references
References 13 publications
(6 reference statements)
2
12
0
2
Order By: Relevance
“…In the present study, we found that the efficacy of NB‐UVB therapy in psoriasis varies with different types of the disease. The morphologic type of psoriasis had no influence on the reduction of the PASI, as reported in previous studies (7, 9). However, Picot et al reported that the degree of infiltration of the lesions and their location on the lower limbs could be a factor in the therapeutic results (9).…”
Section: Discussionsupporting
confidence: 84%
See 1 more Smart Citation
“…In the present study, we found that the efficacy of NB‐UVB therapy in psoriasis varies with different types of the disease. The morphologic type of psoriasis had no influence on the reduction of the PASI, as reported in previous studies (7, 9). However, Picot et al reported that the degree of infiltration of the lesions and their location on the lower limbs could be a factor in the therapeutic results (9).…”
Section: Discussionsupporting
confidence: 84%
“…Animal studies suggest the TL‐01 lamp is two to three times more carcinogenic than broad‐band sources (4). Therefore, additional therapies such as retinoids, calcipotriol, and dithranol with NB‐UVB therapy can be used in order to increase the effectiveness over monotherapy and to allow possible reductions in the cumulative dose of UVB, thus diminishing the potential risk of long‐term treatment (2, 7).…”
Section: Discussionmentioning
confidence: 99%
“…[13] Topical therapies, such as calcipotriene, tazarotene and anthralin, combined with NB-UVB will enhance the efficacy of both modalities and decrease the overall exposure to UV radiation. [1416] The combination of acitretin with NB-UVB (Re-NB-UVB) appears to have synergistic effects and may decrease the time to clearance and the overall exposure to both modalities. [1718] The acute dose-dependent side effects of NB-UVB are erythema, burning, pigmentation and rare transient lesional blistering.…”
Section: Resultsmentioning
confidence: 99%
“…In order to reduce cumulative UV doses and to enhance clearance of psoriasis lesions, combination therapies with topical as well as systemic agents have been established: nUVB plus dithranol (Ingram): In many studies the efficacy of dithranol combined with UVB (broadband or narrowband) could be shown (7,52,53). As dithranol is difficult to handle, this therapy is mainly reserved for hospital settings.…”
Section: Psoriasismentioning
confidence: 99%